Logo-bi
Original Research
Mohammad Mostafa Pourseif, Mitra Yousefpour*, Mohammad Aminianfar, Gholamali Moghaddam, Ahmad Nematollahi ORCID
Bioimpacts. 2019;9(3): 131-144. doi: 10.15171/bi.2019.18
PMCID: PMC6726745     PMID: 31508329     Scopus ID: 85071191509    
The minigene vaccine construct is designed based on the B and T cell epitopes of E. granulosus enolase protein, and ligands for TLR-2 and TLR-4. The minigene vaccine showed stable properties for proper binding with the Toll-like receptors.
Original Research
Aditya Rao Rao Shimoga Janakirama* ORCID, Suma Mathad Shivayogi, Jamuna Kolkar Satyanarayana, Ramesh Chapeyil Kumaran
BioImpacts. 2021;11(3): 187-197. doi: 10.34172/bi.2021.09
PMCID: PMC8314033     PMID: 34336607     Scopus ID: 85106345298    
From Phytochemicals to Biologically active natural product drugs.
Original Research
Khalil EL Khatabi ORCID, Ilham Aanouz, Marwa Alaqarbeh, Mohammed Aziz Ajana, Tahar Lakhlifi, Mohammed Bouachrine* ORCID
BioImpacts. 2022;12(2): 107-113. doi: 10.34172/bi.2021.22143
PMCID: PMC8905587     PMID: 35411302     Scopus ID: 85127183196    
Molecular docking was performed to explore the binding affinity of the 12 selected molecules in the target enzyme and then evaluated for in silico ADMET properties. The best hits were subjected to molecular dynamics simulation.
Letter to the Editor COVID-19
Yosef Masoudi-Sobhanzadeh* ORCID
Bioimpacts. 2020;10(3): 205-206. doi: 10.34172/bi.2020.25
PMCID: PMC7416005     PMID: 32793443     Scopus ID: 85089710496    
This letter aims to introduce drug repurposing methods and the existing challenges to detect candidate drugs which may be helpful in controlling COVID-19.
Original Research
Raja Rajeswari Rajeshkumar ORCID, Banoth Karan Kumar ORCID, Pavadai Parasuraman ORCID, Theivendren Panneerselvam ORCID, Krishnan Sundar ORCID, Damodar Nayak Ammunje ORCID, Sureshbabu Ram Kumar Pandian ORCID, Sankaranarayanan Murugesan ORCID, Shanmugampillai Jeyarajaguru Kabilan ORCID, Selvaraj Kunjiappan*
BioImpacts. 2022;12(6): 487-499. doi: 10.34172/bi.2022.24113
PMCID: PMC9809135     PMID: 36644543     Scopus ID: 85143350606    
The bioactive compounds from Cynodon dactylon potentially degrade the α-Syn aggregation in the brain through in silico molecular docking investigations. A molecular dynamics simulation confirms the stability of the α-Syn-ligand complex.
Original Article
Snehal Aditya Arvindekar* ORCID, Sanket Rathod ORCID, Prafulla Balkrishna Choudhari ORCID, Pradnya Kiran Mane ORCID, Aditya Umesh Arvindekar* ORCID, Suraj Narayan Mali ORCID, Bapu Thorat ORCID
Bioimpacts. 2024;14(5): 27783. doi: 10.34172/bi.2024.27783
PMCID: PMC11406427     PMID: 39296803     Scopus ID: 85208470319    
Original Article
Mark Andrian B. Macalalad ORCID, Fredmoore L. Orosco* ORCID
Bioimpacts. 2025;15: 30815 | Published on: 2025 Oct 21. doi: 10.34172/bi.30815
PMCID: PMC12579737     PMID: 41185869    

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMedPubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science IndicatorsEmbase; EBSCOhost; CAS: DOAJSHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons